ArticleFrontiers in oncology2019

Targeting the Innate Immune Kinase IRAK1 in Radioresistant Cancer: Double-Edged Sword or One-Two Punch?

Peter H Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.